- CA$185.13m
- CA$337.47m
- CA$111.65m
- 37
- 45
- 89
- 58
Annual income statement for Anaergia, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | R2022 December 31st | C2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS/A | ARS/A | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 111 | 127 | 162 | 147 | 112 |
| Cost of Revenue | |||||
| Gross Profit | 21.7 | 23.4 | 26.7 | 19.7 | 25.6 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 121 | 140 | 199 | 321 | 158 |
| Operating Profit | -10.1 | -12.7 | -36.8 | -174 | -46.3 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -18.3 | -14 | -64.5 | -201 | -49.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -21.4 | -15.6 | -79 | -193 | -55.9 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -27.3 | -17.4 | -68.6 | -183 | -42.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -27.3 | -17.4 | -68.6 | -183 | -42.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.49 | -0.334 | -1.09 | -1.63 | -0.273 |
| Dividends per Share |